31225766Behdad A, Boddy CS, Fought AJ, Taxter T, Falkiewicz MK, Ayers E, Chen QC, Chen YH, Karmali R, Pro B, Winter JN, Landsburg DJ, Gordon LI, Kaplan JBLeukemia & lymphomaCell Transformation, Neoplastic; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Neoplasms, Multiple Primary; Neoplasms, Second PrimaryAged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Female; Gene Rearrangement; Humans; Male; Middle Aged; Progression-Free Survival; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Retrospective Studies; Rituximab; Time FactorsSurvival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status. Leuk Lymphoma. 2019 12; 60(13):3266-3271.Leuk Lymphoma2019-06-21T00:00:002019Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.prns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAuthorshipvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedInformationResourcelinked information resourcerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptD019253Chemicals & Drugs17280.989742Proto-Oncogene Proteins c-bcl-2D000368Living Beings46094410.373165AgedAuthorship 357660.3591830.3591831authors10.2519has subject areaD008224Disorders340.998099Lymphoma, FollicularD002471Disorders15340.972779Cell Transformation, NeoplasticD015321Physiology8100.997084Gene RearrangementD016609Disorders15300.971279Neoplasms, Second PrimaryD008875Concepts & IdeasLiving Beings48498180.3737Middle AgedD016403Disorders10240.97235Lymphoma, Large B-Cell, DiffuseD012189Concepts & Ideas34732730.517336Retrospective StudiesD008297Physiology565156330.299056MaleD016271Chemicals & Drugs15210.991554Proto-Oncogene Proteins c-mycD051560Chemicals & Drugs330.998834Proto-Oncogene Proteins c-bcl-6D005260Physiology580162050.293542FemaleD013997Concepts & Ideas34316150.70981Time FactorsD000971Procedures542900.853608Antineoplastic Combined Chemotherapy ProtocolsD009378Disorders17310.972025Neoplasms, Multiple PrimaryD006801Living Beings644293510.211905HumansD00006928326530.978073RituximabD00007432213180.971197Antineoplastic Agents, Immunological